PharmaTimes -
October 2022

King-sized quest

When I spoke to you last month Boris Johnson was Prime Minister and HM Elizabeth II was Head of State. There are, indeed, decades where nothing happens and there are weeks when decades happen. And, in one particular week, Liz Truss moved into Downing Street and King Charles III into Buckingham Palace. Everything changed.

Irrespective of one’s views on institutions and traditions, anyone that does something for 70 years deserves to be saluted.

And, whether you believe in an interventionalist King, it should surely be agreed that a King (with an interest in the environmental issues) should intervene when it comes to climate change – when it comes to an existential crisis.

Pharma remains a massive part of the climate conundrum. Like all other industries, we are simply not doing enough – operating in the margins, setting arbitrary targets of 30% and generally giving ourselves ‘until 2030’ or even 2050! Wildfires, weird heatwaves and rising temperatures suggest that what we’re doing isn’t going to cut it.

Part of the problem is the wider culture of governments convincing us that ‘recycling our Evian bottles’ is the solution. In reality, we need to go bigger – much bigger.  Companies need to cut their air travel timetables (the elephant in the room), not by 20%, but by 90%.

Supply chains need to be radically overhauled and people within industry need to be treated with parity regardless of background, identity and ethnicity. After all, health inequalities remain inseparably linked to the environment.

Pharma is a brilliant, unique industry. We saved the world once and we can do it again,


October 2022 - magazine highlights

Thumbnail image for Mind the gap

Mind the gap

UK healthcare has been dubbed an institution made by men for men, but the NHS is on the cusp of an integral change

Thumbnail image for Brainwave


Brain health vs mental health – redefining how neurological conditions are understood

Thumbnail image for Net result

Net result

How the laboratory industry can tackle carbon emissions when developing drugs

Thumbnail image for One step beyond

One step beyond

Getting closer to the patient – pharma industry reputation in a post-COVID landscape

Thumbnail image for The X Factor

The X Factor

Elevating the voices of rare disease patients has never been more vital

Latest jobs from #PharmaRole

View all

Project Director

Our client is an independent medical communications agency that works with publications, meetings, training materials,...
£65,000 - £75,000 yearly

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.